Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Roberts
John D
JD
Massey Cancer Center, Virginia Commonwealth University, Medical College of Virginia, Richmond, USA. john.d.roberts@vcu.edu
Smith
Mitchell R
MR
Feldman
Eric J
EJ
Cragg
Louise
L
Grant
Steven
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D054713:Bryostatins; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D018942:Macrolides; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D054713:Bryostatins; D007783:Lactones; D018942:Macrolides; C046785:bryostatin 1; D014740:Vidarabine; C024352:fludarabine